5th International Conference and Exhibition on Metabolomics
Bayer Pharma AG, Germany
Dr. Björn Riefke completed his PhD in Biology in 1994 from Heinrich-Heine-University in Duesseldorf, Germany. Since 1994 he have worked in various positions in research and development of former Schering AG and since 2006 of Bayer Pharma AG. He is head of Metabolic Profiling and Clinical Pathology Group in Toxicology and since then involved in the establishment of metabolic profiling platform supporting projects in toxicology, biomarker research and pharmacology.